EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY 4.0

Effect of prebiotic oligosaccharides on bowel habit and the gut microbiota in children with functional constipation (Inside study): study protocol for a randomised, placebo-controlled, multi-centre trial

Carrie A M Wegh, Margriet H C Schoterman, Elaine E Vaughan, Sofie C C van der Zalm, Hauke Smidt, Clara Belzer, Marc A Benninga

Trials · 2024

DOI: 10.1186/s13063-024-08050-8 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift Trials, 2024. Verfasst von Carrie A M Wegh und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatric Gastroenterology and Nutrition, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands…. Hauptthemen laut MEDLINE: Constipation, Defecation, Gastrointestinal Microbiome. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Topconsortium voor Kennis en Innovatie.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Functional constipation (FC) in children is a common gastrointestinal disorder with a worldwide-pooled prevalence of 9.5%. Complaints include infrequent bowel movements, painful defecation due to hard and/or large stools, faecal incontinence, and abdominal pain. Prebiotic oligosaccharides have been shown to relieve constipation symptoms in young adults and elderly. However, sufficient evidence is lacking linking additional prebiotic intake to improve symptoms in children with FC. We hypothesise that prebiotic oligosaccharides are able to relieve symptoms of constipation in young children as well.

Methods

In the present randomised, double-blind, placebo-controlled, multi-centre study, we will study the effects of two prebiotic oligosaccharides in comparison to placebo on constipation symptoms in children of 1–5 years (12 to 72 months) of age diagnosed with FC according to the Rome IV criteria for functional gastrointestinal disorders. The primary outcome measure will be change in stool consistency. Secondary outcomes include stool frequency and stool consistency in a number of cases (%). Tertiary outcomes include among others painful defecation, use of rescue medication, and quality of life. In addition, the impact on gut microbiome outcomes such as faecal microbiota composition and metabolites will be investigated. Participants start with a run-in period, after which they will receive supplements delivered in tins with scoops for 8 weeks, containing one of the two prebiotic oligosaccharides or placebo, followed by a 4-week wash-out period.

Discussion

This randomised double-blind, placebo-controlled multi-centre study will investigate the effectiveness of prebiotic oligosaccharides in children aged 1–5 years with FC.

Trial registration

ClinicalTrials.gov NCT04282551. Registered on 24 February 2020.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ConstipationDefecationGastrointestinal MicrobiomeChild, PreschoolHumansDouble-Blind MethodHabitsMulticenter Studies as TopicOligosaccharidesPrebioticsQuality of LifeRandomized Controlled Trials as TopicTreatment OutcomeInfant

Stichwörter der Autor:innen

Bowel habitFunctional constipationGastroenterologyGut microbiotaNutritionOligosaccharidesPaediatricsPrebioticStool consistencyStool frequency

Substanzen

OligosaccharidesPrebiotics

Autor:innen und Institutionen

  • Department of Paediatric Gastroenterology and Nutrition, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands. carriewegh@gmail.com.
  • Laboratory of Microbiology, Wageningen University & Research, Wageningen, The Netherlands. carriewegh@gmail.com.
  • FrieslandCampina, Amersfoort, The Netherlands.
  • Sensus (Royal Cosun), Roosendaal, The Netherlands.
  • Laboratory of Microbiology, Wageningen University & Research, Wageningen, The Netherlands.
  • Laboratory of Microbiology, Wageningen University & Research, Wageningen, The Netherlands. hauke.smidt@wur.nl.

Förderung

  • Topconsortium voor Kennis en Innovatie

Zitieren

APA

Wegh, C. A. M., Schoterman, M. H. C., Vaughan, E. E., van der Zalm, S. C. C., Smidt, H., Belzer, C., & A Benninga, M. (2024). Effect of prebiotic oligosaccharides on bowel habit and the gut microbiota in children with functional constipation (Inside study): study protocol for a randomised, placebo-controlled, multi-centre trial. Trials. https://doi.org/10.1186/s13063-024-08050-8

Vancouver

Wegh CAM, Schoterman MHC, Vaughan EE, van der Zalm SCC, Smidt H, Belzer C, et al. Effect of prebiotic oligosaccharides on bowel habit and the gut microbiota in children with functional constipation (Inside study): study protocol for a randomised, placebo-controlled, multi-centre trial. Trials. 2024. doi:10.1186/s13063-024-08050-8

BibTeX
@article{Wegh2024,
  author = {Wegh, Carrie A M and Schoterman, Margriet H C and Vaughan, Elaine E and van der Zalm, Sofie C C and Smidt, Hauke and Belzer, Clara and A Benninga, Marc},
  title = {Effect of prebiotic oligosaccharides on bowel habit and the gut microbiota in children with functional constipation (Inside study): study protocol for a randomised, placebo-controlled, multi-centre trial},
  journal = {Trials},
  year = {2024},
  doi = {10.1186/s13063-024-08050-8}
}
Kostenlos starten →